We call this antiangiogenic therapy, and it's completely different from chemotherapy, because it selectively aims at the blood vessels that are feeding the cancers.
Me kutsume seda antiangiogeenseks teraapiaks ja see erineb täiesti keemiaravist, sest ta on suunatud valikuliselt ainult vähkkasvajat toitvatele veresoontele.